CentoRx update

CNTO provided a clinical progress update in its quarterly conference call.

The 1,400-patient European Capture trial of CentoRx gpIIb/IIIa inhibitor for unstable angina, renamed ReoPro, is

Read the full 261 word article

How to gain access

Continue reading with a
two-week free trial.